100 related articles for article (PubMed ID: 7965644)
1. Improved detection of HTLV-II antibody using a whole viral lysate-based EIA.
Kline RL; Vlahov D; Quinn TC
J Acquir Immune Defic Syndr (1988); 1994 Dec; 7(12):1291-2. PubMed ID: 7965644
[No Abstract] [Full Text] [Related]
2. Lack of specificity of HTLV antibody enzyme immunoassays.
Jang D; Mahony JB; Sellors JW; Galli R; Gregory B; Chernesky MA
J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Aug; 9(5):523-4. PubMed ID: 7627628
[No Abstract] [Full Text] [Related]
3. Diagnosis and differentiation of HTLV-I and HTLV-II infection by enzyme immunoassays using synthetic peptides.
Viscidi RP; Hill PM; Li SJ; Cerny EH; Vlahov D; Farzadegan H; Halsey N; Kelen GD; Quinn TC
J Acquir Immune Defic Syndr (1988); 1991; 4(12):1190-8. PubMed ID: 1941526
[TBL] [Abstract][Full Text] [Related]
4. HTLV-I/II indeterminate serology and natural killer cell expansion.
Picchio GR; Bare P; Savignano R; Perez-Bianco R; Yamashita M; Hayami M
J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Aug; 12(4):428-31. PubMed ID: 8673555
[No Abstract] [Full Text] [Related]
5. [Retrovirus: diagnostic tests and their interpretation (II). HIV-2, HTLV-I, and HTLV-II infection].
Soriano V; Gutiérrez M; González-Lahoz J
Med Clin (Barc); 1993 Sep; 101(7):264-8. PubMed ID: 7746003
[No Abstract] [Full Text] [Related]
6. Performances of HTLV serological tests in diagnosing HTLV infection in high-risk population of São Paulo, Brazil.
Jacob F; Santos-Fortuna Ede L; Azevedo RS; Caterino-de-Araujo A
Rev Inst Med Trop Sao Paulo; 2007; 49(6):361-4. PubMed ID: 18157402
[TBL] [Abstract][Full Text] [Related]
7. Serological patterns and temporal trends of HTLV-1/2 infection in high-risk populations attending Public Health Units in São Paulo, Brazil.
Jacob F; Santos-Fortuna E; Azevedo RS; Caterino-de-Araujo A
J Clin Virol; 2008 Jun; 42(2):149-55. PubMed ID: 18346935
[TBL] [Abstract][Full Text] [Related]
8. Detection of human T-lymphotropic virus (HTLV) tax sequences in New York City blood donors seronegative for HTLV types 1 and 2.
Dezzutti CS; Guenthner PC; Daniel S; Utz U; Cabrera T; Marshall JH; Bianco C; Lal RB; Cowan EP
Clin Diagn Lab Immunol; 2003 Jul; 10(4):715-7. PubMed ID: 12853410
[TBL] [Abstract][Full Text] [Related]
9. Difficulties in the diagnosis of HTLV-2 infection in HIV/AIDS patients from Brazil: comparative performances of serologic and molecular assays, and detection of HTLV-2b subtype.
Morimoto HK; Morimoto AA; Reiche EM; Ueda LT; Matsuo T; Reiche FV; Caterino-de-Araujo A
Rev Inst Med Trop Sao Paulo; 2007; 49(4):225-30. PubMed ID: 17823751
[TBL] [Abstract][Full Text] [Related]
10. Comparison of six commercial human T-cell lymphotropic virus type I (HTLV-I) enzyme immunoassay kits for detection of antibody to HTLV-I and -II.
Cossen C; Hagens S; Fukuchi R; Forghani B; Gallo D; Ascher M
J Clin Microbiol; 1992 Mar; 30(3):724-5. PubMed ID: 1551991
[TBL] [Abstract][Full Text] [Related]
11. Heterogeneous geographic distribution of human T-cell lymphotropic viruses I and II (HTLV-I/II): serological screening prevalence rates in blood donors from large urban areas in Brazil.
Catalan-Soares B; Carneiro-Proietti AB; Proietti FA;
Cad Saude Publica; 2005; 21(3):926-31. PubMed ID: 15868051
[TBL] [Abstract][Full Text] [Related]
12. Modified Western blot assay for confirmation and differentiation of human T cell lymphotropic virus types I and II.
Lipka JJ; Santiago P; Chan L; Reyes GR; Samuel KP; Blattner WA; Shaw GM; Hanson CV; Sninsky JJ; Foung SK
J Infect Dis; 1991 Aug; 164(2):400-3. PubMed ID: 1856487
[TBL] [Abstract][Full Text] [Related]
13. Specificity of HTLV antibody enzyme immunoassay.
Ferreira Júnior OC; Vaz RS; Carvalho MB; Hamerschlak N; Ferreira MM; Novoa P
J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Aug; 12(5):526-7. PubMed ID: 8757434
[No Abstract] [Full Text] [Related]
14. HTLV-I/II antibodies among three different Indian groups from Paraguay.
de Cabral MB; Vera ME; Samudio M; Arias AR; Cabello A; Moreno R; Zapiola I; Bouzas MB; Muchinik G
J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Dec; 19(5):548-9. PubMed ID: 9859972
[No Abstract] [Full Text] [Related]
15. HTLV-II among pygmies from Cameroon.
Froment A; Delaporte E; Dazza MC; Larouzé B
AIDS Res Hum Retroviruses; 1993 Aug; 9(8):707. PubMed ID: 8217339
[No Abstract] [Full Text] [Related]
16. Evaluation of a new, fully automated immunoassay for detection of HTLV-I and HTLV-II antibodies.
Qiu X; Hodges S; Lukaszewska T; Hino S; Arai H; Yamaguchi J; Swanson P; Schochetman G; Devare SG
J Med Virol; 2008 Mar; 80(3):484-93. PubMed ID: 18205214
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of antibodies to HTLV-I/II in blood donors and risk populations in South China.
Cao F; Ji Y; Huang R; Lin S
Vox Sang; 1998; 75(2):154. PubMed ID: 9784671
[No Abstract] [Full Text] [Related]
18. Evaluation of a combined lysate/recombinant antigen anti-HTLV-I/II ELISA in high and low endemic areas of HTLV-I/II infection.
Vrielink H; Sisay Y; Reesink HW; Woerdeman M; Winkel C; de Leeuw SJ; Lelie PN; van der Poel CL
Transfus Med; 1995 Jun; 5(2):135-7. PubMed ID: 7655577
[TBL] [Abstract][Full Text] [Related]
19. Serological speciation of human T-cell leukaemia virus infections using synthetic peptide antigens.
Tosswill JH; McAlpine L; Mortimer PP
J Med Virol; 1993 May; 40(1):83-5. PubMed ID: 8099946
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of a new screening assay for HTLV-1 and -2 antibodies for large-scale use.
Malm K; Kjerstadius T; Andersson S
J Med Virol; 2010 Sep; 82(9):1606-11. PubMed ID: 20648617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
